Medication info

Eltoget 10/10 mg Tablets

Prescription medicationTabletExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletAtorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Erisun Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP packaging (Alu-Alu) x 3], 30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 202101640 · Approved 2021.02.18

This product's status changed to Expired on 2026.02.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed dyslipidemia
Who uses it
Adults
Adult dosage
This medicine is administered once daily, with or without food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range of this medicine is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients who require a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40mg once daily. After starting treatment with this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful.

Ingredients

Manufacturer
Erisun Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is used as an adjunct to diet for reducing elevated total cholesterol, LDL cholesterol, apo B protein, triglycerides, and non-HDL cholesterol, as well as increasing HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. It also helps reduce cholesterol levels in patients with homozygous familial hypercholesterolemia, used alone or in combination with other lipid-lowering treatments. This medication is used when there is an inadequate response to appropriate dietary measures and non-pharmacological interventions for dyslipidemia, and it is important to ascertain any other secondary causes in the patient before administration. Appropriate measures should be taken based on lipid test results, particularly in high-risk patients where risk factors should be considered thoroughly. This medication helps reduce cardiovascular disease risk and improve lipid levels.

Dosage and Administration

Adult dosage

This medicine is administered once daily, with or without food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range of this medicine is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients who require a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40mg once daily. After starting treatment with this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful.

Precautions

This medication has been reported to cause a rare side effect known as rhabdomyolysis, which can lead to serious muscle damage. Patients who exhibit severe muscle symptoms or are at heightened risk for renal failure should temporarily pause or discontinue this medication. Patients with allergies to any active ingredients or components of this medication, as well as those with liver disease or muscle disorders, should not take it. Pregnant women or those who may become pregnant, as well as nursing mothers, should not use this medication. Additionally, patients who are concurrently taking certain other medications should not be administered this medication. Patients with a history of alcohol abuse, poor liver function, renal issues, or hypothyroidism should use this medication with caution. Elderly patients over 70 years old or those with risk factors for muscle disorders also require caution. Regular liver function and muscle-related tests should be conducted while using this medication, and any symptoms of muscle pain or drug side effects should prompt immediate consultation with a physician. Moreover, this medication can interact with various drugs, so patients must inform their physician about all other medications they are taking. Pregnant women should use effective contraception when taking this medication as it may pose risks to the fetus, and nursing mothers should also avoid it. Children have not had established safety and efficacy, so this medication is not recommended for them. Elderly patients require caution due to the risk of muscle disorders, but no special dose adjustment is necessary. Patients with severely reduced liver or kidney function should not use this medication or should use it with extreme caution. In the case of overdose, there are no specific antidotes, and symptomatic treatment and supportive therapy should be administered while monitoring liver function and muscle enzyme levels. Store this medication out of reach of children, and do not transfer it into another container. Dizziness may occur while taking this medication, so caution is advised when driving or operating machinery.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, myalgia, abdominal pain, elevated liver enzymes, increased ALT, increased AST, musculoskeletal pain, dizziness, cough, nausea, arthralgia, muscle weakness, hyperkalemia, bronchitis, sinusitis, flushing, intracranial aneurysm, restless legs syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, bradycardia, hypotension, anemia, hernia, vitamin D deficiency, gastric polyps, duodenal polyps, duodenitis, jaundice, erectile dysfunction, breast mass, skin mass, ingrown toenails, thyroid adenoma, lethargy, fatigue, chest pain, peripheral edema, fatigue, fever, rhinitis, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal bloating, dyspepsia, diarrhea, vomiting, belching, pancreatitis, oropharyngeal and laryngeal pain, nosebleed, insomnia, nightmares, headache, paresthesia, sensory loss, taste disorders, amnesia, peripheral neuropathy, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications from rupture, myopathy, myositis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reactions, anaphylaxis, hepatitis, cholestasis, hepatic failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, gynecomastia, increased serum creatine kinase, positive urinary leukocytes, nightmares, vomiting, abdominal abnormalities, hepatitis, cholelithiasis, cholecystitis, drug-induced liver injury, eosinophilia with systemic symptoms accompanying drug reactions, erythema multiforme, fatigue, chest discomfort, edema, weakness, systemic edema, diabetic neuropathy, tremors, epigastric pain, gastritis, dry mouth, epigastric discomfort, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, sputum, frequent urination, cystitis, hematuria, dysuria, kidney stones, nocturia, epididymitis, fibrocystic breast disease, vaginal bleeding, albuminuria, breast enlargement, cervical discharge, nephritis, urinary incontinence, urinary retention, urinary urgency, abnormal ejaculation, uterine bleeding, colored urine, diabetes, hypoglycemia, urticaria, hyperhidrosis, rash, pruritus, upper respiratory tract infection, conjunctival injection, kidney failure, liver dysfunction, increased serum creatinine, hypertension, increased blood urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP packaging (Alu-Alu) x 3], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.